(Q47703344)

4 February 2018

title

The galectin-3/RAGE dyad modulates vascular osteogenesis in atherosclerosis. (English)

1 reference

4 February 2018

1 reference

1

1 reference

4 February 2018

Giuseppe Pugliese

10

1 reference

4 February 2018

author name string

Carla Iacobini

2

1 reference

4 February 2018

Carlo Ricci

3

1 reference

4 February 2018

Claudia Blasetti Fantauzzi

4

1 reference

4 February 2018

Laura Salvi

5

1 reference

4 February 2018

Carlo M Pesce

6

1 reference

4 February 2018

Michela Relucenti

7

1 reference

4 February 2018

Giuseppe Familiari

8

1 reference

4 February 2018

Maurizio Taurino

9

1 reference

4 February 2018

publication date

23 August 2013

1 reference

4 February 2018

published in

Cardiovascular Research

1 reference

4 February 2018

volume

100

1 reference

4 February 2018

issue

3

1 reference

4 February 2018

page(s)

472-480

1 reference

4 February 2018

Vascular calcification mechanisms

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT206

Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: an intravascular ultrasound study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT206

Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT206

Advanced glycation endproducts--role in pathology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT206

Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT206

Accelerated lipid-induced atherogenesis in galectin-3-deficient mice: role of lipoxidation via receptor-mediated mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT206

Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT206

S100A12 in vascular smooth muscle accelerates vascular calcification in apolipoprotein E-null mice by activating an osteogenic gene regulatory program

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT206

Expression of galectin-3 in skeletal tissues is controlled by Runx2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT206

Regulation of osteoclast function and bone mass by RAGE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT206

A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT206

Plaque Neovascularization Is Increased in Ruptured Atherosclerotic Lesions of Human Aorta

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT206

N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT206

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT206

Advanced lipoxidation end-products mediate lipid-induced glomerular injury: role of receptor-mediated mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT206

Runx2-upregulated receptor activator of nuclear factor κB ligand in calcifying smooth muscle cells promotes migration and osteoclastic differentiation of macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT206

Widespread increase in myeloid calcifying cells contributes to ectopic vascular calcification in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT206

In vivo analysis of Wnt signaling in bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT206

Implication of galectin-3 in Wnt signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT206

Receptor for advanced glycation end products inhibits proliferation in osteoblast through suppression of Wnt, PI3K and ERK signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT206

Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT206

Composition of the stable carotid plaque: insights from a multidetector computed tomography study of plaque volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT206

A possible suppressive role of galectin-3 in upregulated osteoclastogenesis accompanying adjuvant-induced arthritis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT206

The roles of lipid oxidation products and receptor activator of nuclear factor-κB signaling in atherosclerotic calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT206

Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT206

A dynamic model of calcific nodule destabilization in response to monocyte- and oxidized lipid-induced matrix metalloproteinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT206

21 January 2018

Identifiers

DOI

10.1093/CVR/CVT206

1 reference

4 February 2018

PubMed ID

23975852

1 reference

4 February 2018